|
More Guidance Needed on Drugmakers’ Responsibilities in Outsourcing, FDA Official Says
Concerned about the upward trend in supplier quality issues, the FDA is considering agency-wide guidance to clarify manufacturers’ responsibilities for outsourcing, an agency official says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives